Nalu Bio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
Nalu Bio General Information
Description
Developer of a drug discovery tool designed to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS). The company's platform combines generative artificial intelligence with emerging science to design, model, and screen novel compounds, enabling the health and wellness market to address critical issues such as pain, weight management, stress, and sleep disorders with minimal side effects on a global scale.
Contact Information
Website
www.nalubio.comCorporate Office
- 38 Keyes Avenue
- Suite 200
- San Francisco, CA 94129
- United States
Corporate Office
- 38 Keyes Avenue
- Suite 200
- San Francisco, CA 94129
- United States
Nalu Bio Timeline
Nalu Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 26-Mar-2025 | Completed | Pre-Clinical Trials | |||
| 3. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 2. Early Stage VC (Series A) | 17-Feb-2023 | $12M | $13.5M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 07-Jan-2021 | $1.5M | $1.5M | Completed | Pre-Clinical Trials |
Nalu Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed | 1,084,506 | $0.000100 | $0.94 | $0.94 | 1x | $0.94 | 5.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nalu Bio Patents
Nalu Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12679847-B1 | Aryl-substituted n-alkyl indoles and their use as pharmacologically active agents | Active | 04-Aug-2025 | ||
| US-12636296-B1 | Cannabinol analogs and their use as pharmacologically active agents | Active | 17-Jul-2025 | ||
| US-20250333392-A1 | Synthesis of (-)-trans-delta-9-tetrahydrocannabivarin (delta-9 thcv) and analogs thereof | Pending | 08-Apr-2024 | ||
| WO-2025217205-A1 | Synthesis of (-)-trans-δ9-tetrahydrocannabivarin (δ9-thcv) and analogs thereof | Pending | 08-Apr-2024 | ||
| WO-2025217205-A4 | Synthesis of (-)-trans-δ9-tetrahydrocannabivarin (δ9-thcv) and analogs thereof | Pending | 08-Apr-2024 | C07D311/80 |
Nalu Bio Signals
Nalu Bio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Springboard Enterprises | Accelerator/Incubator | |||
| Brown Angel Group | Angel Group | Minority | ||
| Intrinsic Capital Partners | Growth/Expansion | Minority | ||
| Portfolia | Venture Capital | Minority | ||
| Sacramento Angels | Angel Group | Minority |
Nalu Bio FAQs
-
When was Nalu Bio founded?
Nalu Bio was founded in 2019.
-
Where is Nalu Bio headquartered?
Nalu Bio is headquartered in San Francisco, CA.
-
What is the size of Nalu Bio?
Nalu Bio has 14 total employees.
-
What industry is Nalu Bio in?
Nalu Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Nalu Bio a private or public company?
Nalu Bio is a Private company.
-
What is Nalu Bio’s current revenue?
The current revenue for Nalu Bio is .
-
How much funding has Nalu Bio raised over time?
Nalu Bio has raised $13.5M.
-
Who are Nalu Bio’s investors?
Springboard Enterprises, Brown Angel Group, Intrinsic Capital Partners, Portfolia, and Sacramento Angels are 5 of 10 investors who have invested in Nalu Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process